JPRN-UMIN000023271已完成未知
Post marketing study of sofosbuvir and ledipasvir for genotype 1 hepatitis C virus infection - Sofosbuvir and ledipasvir for genotype 1 HCV
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) pregnant woman 2) decompensated cirrhosis 3) severe renal dysfunction (<eGFR30)
研究者
相似试验
已完成
不适用
Post marketing study of sofosbuvir and ribavirin for hepatitis C virus genotype 2 infectioHepatitis C virus infectionJPRN-UMIN000023269Wakayama Medical University100
已完成
不适用
Prospective study of Sofosbuvir and Ledipasvir for HCV genotype 1 infected Japanese patientsGenotype 1 infected chronic liver diseasesJPRN-UMIN000019400Osaka City University and affiliated hospitals400
招募中
不适用
Evaluation of the efficacy of sofosbuvir and ledipasvir for Japanese hepatitis C patients: a prospective study in real-life settings.chronic hepatitis CJPRN-UMIN000019468Toranomon Hospital100
尚未招募
不适用
Efficacy and safety of ledipasvir and sofosbuvir in patients with chronic hepatitis CPatients with chronic hepatitis C virus infectionJPRN-UMIN000018561Osaka University Graduate School of Medicine, Department of Gastroenterology and Hepatology2,000
已完成
不适用
Effectiveness and safety of ledipasvir and sofosbuvir for patients infected with HCV genotype 1 in clinical practicesChronic hepatitis C genotype 1JPRN-UMIN000024007Kyushu University1,000